SCHEMBL8166437

SCHEMBL8166437

CCOC(=O)[C@@H]1C[C@H]1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3696263 1.00 — —
SCHEMBL7198390 1.00 — —
SCHEMBL25144056 0.95 CA1 (0.41) —
SCHEMBL25144499 0.88 CA1 (0.37) —
SCHEMBL25144280 0.88 CA1 (0.37) —
SCHEMBL8914013 0.85 ALDH1A1 (0.48) —
SCHEMBL12943060 0.85 ALDH1A1 (0.48) —
SCHEMBL2705849 0.85 ALDH1A1 (0.48) —
SCHEMBL2705851 0.85 ALDH1A1 (0.48) —
SCHEMBL1296897 0.85 ALDH1A1 (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3541804-B1 CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC (US) 2025-01-22 — — EP disclosed
US-11020395-B2 Cycloalkyl substituted triazole compounds as agonists of the APJ receptor AMGEN INC. (US) 2021-06-01 — — US disclosed
US-20190290648-A1 CYCLOALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR AMGEN INC. (US) 2019-09-26 — — US disclosed
US-8815877-B2 Serine/threonine kinase inhibitors GENENTECH, INC. (US) 2014-08-26 — — US disclosed
US-8637537-B2 Serine/threonine kinase inhibitors GENENTECH, INC. (US) 2014-01-28 — — US disclosed
US-20130225620-A1 SERINE/THREONINE KINASE INHIBITORS GENENTECH, INC. (US) 2013-08-29 — — US disclosed
US-20130178486-A1 SERINE/THREONINE KINASE INHIBITORS GENENTECH, INC. (US) 2013-07-11 — — US disclosed
US-6130350-A Process for producing 2-fluorine-1-cyclopropane carboxylic acid derivatives by reductive dehalogenation BAYER AKTIENGESELLSCHAFT (DE) 2000-10-10 — — US disclosed
Send feedback